2771 - 2780 of 7939 Results
Title
Year
- No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects2021RESTRICTEDTitle: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1187End Page: 1192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01657-wCitation Count: 1
- Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up2021OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 11
- Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes2021OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369672Citation Count: 14
- BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease2021OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: http://manuscript.elsevier.com/S1094715922000460/pdf/S1094715922000460.pdfCitation Count: 8
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://air.unimi.it/bitstream/2434/968045/2/Movement%20Disorders%20-%202021%20-%20Laansma%20-%20International%20Multicenter%20Analysis%20of%20Brain%20Structure%20Across%20Clinical%20Stages%20of.pdfCitation Count: 76
- Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life2021OPENTitle: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of lifeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1668End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51424Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/169327/2/acn351424.pdfCitation Count: 8
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 16
- Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models2021OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7
- The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors2021OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 7
- A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s Disease2021RESTRICTEDTitle: A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S27End Page: S34Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202381Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202381?id=journal-of-parkinsons-disease%2Fjpd202381Citation Count: 25